The DOI matches its Crossref record.
GSH/pH dual response drug delivery system for photothermal enhanced gene-immunotherapy
Abstract
GSH/pH dual-responsive nanoparticles was used for gene-photothermal synergistic therapy to cause cell immunogenic death and induce anti-tumor immune response.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Because activated fragments are often neutral to mildly negative, diffusion gains can outpace cellular entry, which encourages coupling shrinkage with a second lever such as latent cation exposure or ligand unmasking so that transport is not achieved at the expense of uptake [22, 24].”
From Overcoming tumor microenvironment barriers: transformable and bioinspired nanomedicine strategies for deep tumor penetration (2026) · cites this paper as [24]
In the citing paper
“When shrinkers are combined with prior microenvironment priming, for example brief courses that lower IFP or soften ECM, the same activated size window, about 20–50 nm, tends to produce more uniform coverage than without priming.”
From Overcoming tumor microenvironment barriers: transformable and bioinspired nanomedicine strategies for deep tumor penetration (2026) · cites this paper as [24]
In the citing paper
“In addition, when the activated entities approach the ultrasmall range, concentration gradients can drive partial back-diffusion toward vessels, and systemic elimination can accelerate once fragments re-enter circulation, collectively increasing the risk of intratumoral washout.”
From Overcoming tumor microenvironment barriers: transformable and bioinspired nanomedicine strategies for deep tumor penetration (2026) · cites this paper as [24]
In the citing paper
“Dual pH/GSH micelles combine charge reversal with disulfide cleavage to co-deliver siPD-L1 and indocyanine green, aligning photothermal guidance with checkpoint silencing [24].”
From Overcoming tumor microenvironment barriers: transformable and bioinspired nanomedicine strategies for deep tumor penetration (2026) · cites this paper as [24]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 41
- Giaquinto, 2022, CA Cancer J. Clin., 72, 524, 10.3322/caac.21754 · DOI
- Gui, 2019, J. Natl. Cancer Inst., 111, 903, 10.1093/jnci/djz105 · DOI
- Song, 2016, Adv. Mater., 28, 7143, 10.1002/adma.201602111 · DOI · Paper page
- Sun, 2017, J. Controlled Release, 264, 145, 10.1016/j.jconrel.2017.08.034 · DOI
- Tang, 2021, Nano Today, 37, 101083, 10.1016/j.nantod.2021.101083 · DOI
- Wan, 2020, Chem. Eng. J., 380, 122458, 10.1016/j.cej.2019.122458 · DOI
- Wang, 2022, Adv. Sci., 9, 2202332, 10.1002/advs.202202332 · DOI
- Gulzar, 2020, Inorg. Chem., 59, 4909, 10.1021/acs.inorgchem.0c00170 · DOI
- Gulzar, 2020, Inorg. Chem., 59, 4909, 10.1021/acs.inorgchem.0c00170 · DOI
- Bian, 2021, ACS Appl. Nano Mater., 4, 11353, 10.1021/acsanm.1c01903 · DOI
- Li, 2021, Chem. Eng. J., 417, 128844, 10.1016/j.cej.2021.128844 · DOI
- Zhao, 2021, ACS Nano, 15, 6517, 10.1021/acsnano.0c08790 · DOI
- Hu, 2022, Chem. Sci., 13, 7355, 10.1039/D2SC01769E · DOI
- Li, 2022, Acta Biomater., 154, 454, 10.1016/j.actbio.2022.10.008 · DOI
- Sobhana, 2023, Nanotheranostics, 7, 41, 10.7150/ntno.76720 · DOI
- Porcu, 2016, Biotechnol. Adv., 34, 768, 10.1016/j.biotechadv.2016.04.001 · DOI
- Zhang, 2022, Nano Today, 43, 101418, 10.1016/j.nantod.2022.101418 · DOI
- Ding, 2022, Small, 18, 2104132, 10.1002/smll.202104132 · DOI
- Li, 2022, Adv. Sci., 9, 2201734, 10.1002/advs.202201734 · DOI
- Li, 2021, Adv. Mater., 33, 2008481, 10.1002/adma.202008481 · DOI
- Li, 2020, Adv. Funct. Mater., 30, 1909745, 10.1002/adfm.201909745 · DOI
- Shang, 2020, Biomater. Sci., 8, 5241, 10.1039/D0BM01158D · DOI
- Shen, 2022, Biomaterials, 283, 121428, 10.1016/j.biomaterials.2022.121428 · DOI
- Kwak, 2017, ACS Nano, 11, 10135, 10.1021/acsnano.7b04717 · DOI
- Kwak, 2019, Mol. Pharm., 16, 4940, 10.1021/acs.molpharmaceut.9b00826 · DOI
- Liu, 2022, ACS Nano, 16, 7409, 10.1021/acsnano.1c09794 · DOI
- Mu, 2021, Nanoscale, 13, 8998, 10.1039/D0NR08024A · DOI
- Lamberti, 2020, Pharmaceutics, 12, 178, 10.3390/pharmaceutics12020178 · DOI
- Subhan, 2020, Nanomedicine, 29, 102239, 10.1016/j.nano.2020.102239 · DOI
- Whitehead, 2009, Nat. Rev. Drug Discovery, 8, 129, 10.1038/nrd2742 · DOI · Paper page
- Chen, 2021, Biomacromolecules, 22, 5139, 10.1021/acs.biomac.1c01109 · DOI
- Yan, 2022, J. Controlled Release, 342, 241, 10.1016/j.jconrel.2022.01.008 · DOI · Paper page
- Zhang, 2016, Adv. Healthcare Mater., 5, 2776, 10.1002/adhm.201600633 · DOI
- Aghamiri, 2021, Biotechnol. Bioeng., 118, 3669, 10.1002/bit.27869 · DOI
- Tang, 2006, J. Biomater. Sci., Polym. Ed., 17, 461, 10.1163/156856206776374133 · DOI
- Xiao, 2022, Nano Today, 47, 101632, 10.1016/j.nantod.2022.101632 · DOI
- Wang, 2022, Chem. Sci., 13, 5345, 10.1039/D2SC01672A · DOI
- Cheng, 2021, Biomaterials, 275, 120964, 10.1016/j.biomaterials.2021.120964 · DOI
- Fucikova, 2020, Cell Death Dis., 11, 1013, 10.1038/s41419-020-03221-2 · DOI · Paper page
- Gurung, 2020, Biomaterials, 247, 119984, 10.1016/j.biomaterials.2020.119984 · DOI · Paper page
- Sakaguchi, 2005, Nat. Immunol., 6, 345, 10.1038/ni1178 · DOI · Paper page
Cited by
Sorted by citations
Sheng, J., Yuan, W., Zhang, M., Chen, Z., Qi, Y., Zhao, Y., & Zhang, S. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04028-7 · Cited by 35
Metadata
- Authors
- Ma, T., Li, W., Ye, J., Huang, C., Li, Y., Qiu, H., & Yin, S.
- Venue
- Nanoscale
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2023
- Volume
- 15
- Issue
- 42
- Pages
- 16947-16958
- ISSN
- 2040-3364
- 2040-3372
- Cited by
- 21
- References
- 0
- Language
- en
- Funders
- Natural Science Foundation of Zhejiang Province (LY23E030011, LZ23B040001)
- Zhejiang Provincial Ten Thousand Plan for Young Top Talents (2019R52040)
- National Natural Science Foundation of China (21971049, 51903070)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
